SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter before market open on Tuesday, October 31, 2023.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Offering is designed to enhance time to value, provide a predictable cost model and to…
Landmark partnership combines nationwide group purchasing power with advanced remote patient care programs to expand…
Parents Urged More Platforms To Adopt SafeguardsWASHINGTON, Sept. 14, 2026 /PRNewswire/ -- The Coalition to…
SHANGHAI, Sept. 14, 2026 /PRNewswire/ -- MoleculeMind, an AI-native bioengineering infrastructure company, announced that research on…
Medical device company relied on Greenlight Guru's eQMS to stay audit ready across ISO 13485,…
Newly released AI capabilities help healthcare organizations obtain verifiable answers grounded in reliable dataSEATTLE, Sept.…